These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8998950)

  • 21. Comparison of three physiologically based pharmacokinetic models of benzene disposition.
    Bois FY; Woodruff TJ; Spear RC
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):79-88. PubMed ID: 1871774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fuzzy physiologically based pharmacokinetic modeling framework to predict drug disposition in humans.
    Seng KY; Vicini P; Nestorov IA
    Conf Proc IEEE Eng Med Biol Soc; 2006; Suppl():6485-8. PubMed ID: 17959432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish.
    Khazaee M; Ng CA
    Environ Sci Process Impacts; 2018 Jan; 20(1):105-119. PubMed ID: 29265128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologically based pharmacokinetic model for quinocetone in pigs and extrapolation to mequindox.
    Zhu X; Huang L; Xu Y; Xie S; Pan Y; Chen D; Liu Z; Yuan Z
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2017 Feb; 34(2):192-210. PubMed ID: 28001497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically-based pharmacokinetic model for evaluating gender-specific exposures of N-nitrosodimethylamine (NDMA).
    Kang DW; Kim JH; Choi GW; Cho SJ; Cho HY
    Arch Toxicol; 2024 Mar; 98(3):821-835. PubMed ID: 38127128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncertainty and variability in the exposure reconstruction of chemical incidents--the case of acrylonitrile.
    Huizer D; Ragas AM; Oldenkamp R; van Rooij JG; Huijbregts MA
    Toxicol Lett; 2014 Dec; 231(3):337-43. PubMed ID: 25050995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies.
    Glassman PM; Balthasar JP
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):427-46. PubMed ID: 27377311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologically based pharmacokinetic model use in risk assessment--Why being published is not enough.
    McLanahan ED; El-Masri HA; Sweeney LM; Kopylev LY; Clewell HJ; Wambaugh JF; Schlosser PM
    Toxicol Sci; 2012 Mar; 126(1):5-15. PubMed ID: 22045031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment.
    Krishnan K; Johanson G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):31-53. PubMed ID: 16291521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification.
    Krauss M; Burghaus R; Lippert J; Niemi M; Neuvonen P; Schuppert A; Willmann S; Kuepfer L; Görlitz L
    In Silico Pharmacol; 2013; 1():6. PubMed ID: 25505651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
    Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
    Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.
    Tan YM; Liao KH; Conolly RB; Blount BC; Mason AM; Clewell HJ
    J Toxicol Environ Health A; 2006 Sep; 69(18):1727-56. PubMed ID: 16864423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifetime PCB 153 bioaccumulation and pharmacokinetics in pilot whales: Bayesian population PBPK modeling and Markov chain Monte Carlo simulations.
    Weijs L; Roach AC; Yang RS; McDougall R; Lyons M; Housand C; Tibax D; Manning T; Chapman J; Edge K; Covaci A; Blust R
    Chemosphere; 2014 Jan; 94():91-6. PubMed ID: 24080004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.
    Mörk AK; Jonsson F; Johanson G
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):423-32. PubMed ID: 19660484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic reanalysis of a Diazepam PBPK model: a comparison of Stan and GNU MCSim.
    Tsiros P; Bois FY; Dokoumetzidis A; Tsiliki G; Sarimveis H
    J Pharmacokinet Pharmacodyn; 2019 Apr; 46(2):173-192. PubMed ID: 30949914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.
    Glassman PM; Chen Y; Balthasar JP
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):527-40. PubMed ID: 26364301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.
    Al-Subeihi AA; Alhusainy W; Kiwamoto R; Spenkelink B; van Bladeren PJ; Rietjens IM; Punt A
    Toxicol Appl Pharmacol; 2015 Mar; 283(2):117-26. PubMed ID: 25549870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output.
    Farrar D; Allen B; Crump K; Shipp A
    Toxicol Lett; 1989 Dec; 49(2-3):371-85. PubMed ID: 2690411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
    Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.